SCM
Suvretta Capital Management Portfolio holdings
AUM
$2.65B
This Quarter Return
+0.16%
1 Year Return
+18.59%
3 Year Return
+180.23%
5 Year Return
+278.12%
10 Year Return
+1,101.07%
AUM
$5.88B
AUM Growth
+$5.88B
(-12%)
Cap. Flow
-$648M
Cap. Flow
% of AUM
-11.02%
Top 10 Holdings %
Top 10 Hldgs %
40.93%
Holding
144
New
23
Increased
39
Reduced
15
Closed
39
Top Buys
| 1 |
Thermo Fisher Scientific
TMO
|
$186M |
| 2 |
Alight
ALIT
|
$95.9M |
| 3 |
XYZ
Block, Inc.
XYZ
|
$72.7M |
| 4 |
Twilio
TWLO
|
$64.6M |
| 5 |
Opendoor
OPEN
|
$56.3M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$269M |
| 2 |
Uber
UBER
|
$193M |
| 3 |
Meta Platforms (Facebook)
META
|
$161M |
| 4 |
Paysafe
PSFE
|
$156M |
| 5 |
Apple
AAPL
|
$99.6M |
Sector Composition
| 1 | Healthcare | 32.65% |
| 2 | Consumer Discretionary | 19.24% |
| 3 | Technology | 18.68% |
| 4 | Industrials | 18.41% |
| 5 | Financials | 4.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PNT
51
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $17.1M | 0.29% |
2,225,000
+179,400
| +9% | +$1.38M |
|
52
Bolt Biotherapeutics
BOLT
$9.29M
| $16.8M | 0.28% |
1,325,500
+371,411
| +39% | +$4.7M |
|
53
Heron Therapeutics
HRTX
$204M
| $15.9M | 0.27% |
1,490,440
| – | – |
|
54
Solid Biosciences
SLDB
$448M
| $14.3M | 0.24% |
5,974,193
| – | – |
|
|
DICE
55
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $13.4M | 0.23% |
+410,000
| New | +$13.4M |
|
|
KDNY
56
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $13.4M | 0.23% |
1,047,468
+79,445
| +8% | +$1.01M |
|
57
Kezar Life Sciences
KZR
$28.5M
| $12.2M | 0.21% |
1,409,956
| – | – |
|
58
Rocket Lab Corporation Common Stock
RKLB
$21B
| $12.1M | 0.2% |
+750,000
| New | +$12.1M |
|
|
SIOX
59
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $11.9M | 0.2% |
5,489,000
| – | – |
|
|
CMRX
60
DELISTED
Chimerix, Inc.
CMRX
| $11.8M | 0.2% |
1,907,620
+1,082,379
| +131% | +$6.7M |
|
|
CZOO
61
DELISTED
Cazoo Group Ltd
CZOO
| $11.7M | 0.2% |
1,509,700
-1,492,493
| -50% | -$11.6M |
|
62
Terns Pharmaceuticals
TERN
$651M
| $11.7M | 0.2% |
1,125,736
+600
| +0.1% | +$6.25K |
|
|
INZY
63
DELISTED
Inozyme Pharma
INZY
| $11.4M | 0.19% |
986,400
+621,228
| +170% | +$7.2M |
|
|
RXDX
64
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $11.4M | 0.19% |
480,480
-145,145
| -23% | -$3.44M |
|
|
FSRX
65
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $10.6M | 0.18% |
1,092,600
| – | – |
|
66
BioAtla
BCAB
$28.7M
| $10.4M | 0.18% |
+354,190
| New | +$10.4M |
|
67
Disc Medicine
IRON
$2.14B
| $8.64M | 0.15% |
2,137,823
+2,823
| +0.1% | +$11.4K |
|
68
InflaRx
IFRX
$117M
| $8.51M | 0.14% |
3,285,000
| – | – |
|
69
Evolv Technologies
EVLV
$1.37B
| $8.21M | 0.14% |
+1,367,870
| New | +$8.21M |
|
70
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $7.86M | 0.13% |
+489,333
| New | +$7.86M |
|
|
MOLN
71
Molecular Partners
MOLN
$139M
| $7.84M | 0.13% |
400,000
| – | – |
|
72
Nerdy
NRDY
$159M
| $6.99M | 0.12% |
+700,000
| New | +$6.99M |
|
73
Archer Aviation
ACHR
$5.41B
| $6.66M | 0.11% |
+750,000
| New | +$6.66M |
|
74
AC Immune
ACIU
$227M
| $6.47M | 0.11% |
+963,500
| New | +$6.47M |
|
75
Freshworks
FRSH
$3.81B
| $6.4M | 0.11% |
+150,000
| New | +$6.4M |
|